Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23187,96,1.29 [0.68-2.46],0.4396741485545582
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23822,175,0.78 [0.49-1.23],0.2837477666596002
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23586,1162,0.89 [0.74-1.07],0.2034240999280027
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Candidiasis,23850,410,0.98 [0.72-1.32],0.8798703174139298
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23104,3026,0.86 [0.77-0.97],0.0096866917693965
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23313,2463,0.92 [0.81-1.04],0.1755793186659588
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23604,1170,0.85 [0.71-1.02],0.0779199390231
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23754,78,0.98 [0.49-1.96],0.9492919771039304
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22272,698,0.97 [0.77-1.23],0.8209592482335553
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21513,796,0.91 [0.73-1.13],0.3898565437001526
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21562,218,0.85 [0.56-1.30],0.4586934528168412
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16699,1417,0.84 [0.71-0.99],0.038884143231834
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21374,320,0.83 [0.59-1.17],0.2877638030214038
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23790,1356,0.86 [0.73-1.02],0.0801731834775883
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Mycoses,23903,463,0.94 [0.71-1.25],0.6665646560567822
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23246,822,0.85 [0.69-1.05],0.137959983983197
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23855,764,0.97 [0.78-1.21],0.7914887471182979
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22609,175,0.77 [0.49-1.21],0.2596096948457277
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23960,38,0.71 [0.27-1.87],0.4869175271382173
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23769,678,1.00 [0.79-1.27],0.995117465217277
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23748,72,0.73 [0.36-1.49],0.391350094326952
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23877,168,0.75 [0.47-1.18],0.214709792297471
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23862,153,0.74 [0.46-1.20],0.2179149216444215
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22720,296,0.95 [0.66-1.36],0.7829555004311033
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22650,226,0.88 [0.59-1.33],0.5457936619438173
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22535,101,1.26 [0.68-2.36],0.4645181350262892
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23937,35,1.01 [0.36-2.82],0.9914224546946546
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23893,143,0.75 [0.46-1.25],0.2712130671784754
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral warts,23792,42,0.84 [0.33-2.14],0.7176770367066833
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23822,72,0.63 [0.31-1.26],0.1870524488739262
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm,23715,201,1.21 [0.78-1.87],0.3926361015269055
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23867,61,1.41 [0.64-3.11],0.3944759822596375
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23862,54,0.89 [0.39-2.02],0.773540297041439
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23702,1059,1.13 [0.93-1.36],0.2160552674798608
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of meninges,23936,74,0.83 [0.41-1.69],0.6076426503839205
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23899,60,1.10 [0.49-2.46],0.8144262423213504
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23928,116,0.99 [0.56-1.76],0.978017644370782
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of ovary,23890,150,0.97 [0.59-1.59],0.9056507429116404
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23940,237,1.39 [0.93-2.09],0.1116716642744328
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Caecum,23946,218,0.84 [0.56-1.28],0.4234447506678649
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23879,60,1.07 [0.48-2.39],0.8644586315141528
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Descending colon,23944,132,1.14 [0.67-1.96],0.6256325058240488
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Rectum,23906,246,1.14 [0.77-1.70],0.5037423079943426
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23859,444,1.18 [0.88-1.59],0.2626759149980991
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23945,255,1.00 [0.68-1.47],0.9966541078740248
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Carcinoma in situ of breast,19373,117,1.68 [0.94-2.98],0.0776838655977748
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19444,135,1.35 [0.79-2.31],0.2670336788965541
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19437,30,1.30 [0.41-4.10],0.6497411359250058
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19464,57,0.86 [0.38-1.93],0.7081277372708886
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23900,127,1.29 [0.74-2.24],0.3647379392579413
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma, any site",23901,125,1.27 [0.73-2.21],0.3957956143693005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Leiomyoma of uterus,23077,497,0.92 [0.70-1.20],0.5326027624278825
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Lung cancer and mesothelioma,17201,283,0.78 [0.55-1.13],0.1927082508097782
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Lymphoid leukaemia,19441,34,0.64 [0.23-1.78],0.3906438000238016
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19556,149,1.48 [0.88-2.46],0.1359161013930072
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19506,99,0.72 [0.39-1.31],0.280062459866308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19573,166,1.66 [1.02-2.73],0.0431944677341036
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19469,62,0.56 [0.26-1.18],0.1277757402501627
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19470,63,0.57 [0.27-1.19],0.1355886211136196
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19456,49,0.63 [0.27-1.47],0.2849972921589788
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19531,124,1.12 [0.64-1.97],0.6820712197811055
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19498,91,1.13 [0.59-2.19],0.7090602446198953
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19478,71,0.59 [0.29-1.18],0.1365327081142472
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19442,35,1.14 [0.40-3.28],0.8044021615506657
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19478,71,0.50 [0.25-0.99],0.0478955154525659
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi,23728,205,1.12 [0.73-1.72],0.5896074719430155
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi of trunk,23919,69,1.60 [0.76-3.36],0.2147455646305663
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanoma in situ,19435,76,0.59 [0.30-1.16],0.1265189022691663
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19479,72,0.90 [0.43-1.86],0.7723964976185609
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19540,133,0.67 [0.40-1.13],0.1305328356531779
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19615,208,0.98 [0.64-1.50],0.9225264746139048
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19489,82,0.54 [0.28-1.03],0.0614911917093602
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Other benign neoplasms of skin,23765,151,0.90 [0.55-1.47],0.6651790798296582
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20221,814,0.99 [0.79-1.22],0.8923348306977117
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20257,850,0.96 [0.78-1.18],0.6928542269291058
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23676,340,0.79 [0.57-1.09],0.1533458748039174
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22222,86,1.08 [0.55-2.11],0.8289522906944592
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,71,1.16 [0.56-2.41],0.6970715496837285
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23065,2579,1.01 [0.89-1.14],0.8775758566800602
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22548,27,0.63 [0.20-2.02],0.4402395756949833
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23610,47,0.76 [0.31-1.83],0.5355317267294444
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23447,1311,1.06 [0.89-1.26],0.4941498008121435
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23447,1311,1.06 [0.89-1.26],0.4941498008121435
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22203,67,0.92 [0.44-1.95],0.8305954779508218
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23596,1075,1.12 [0.93-1.36],0.2260981061462182
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23664,101,0.93 [0.50-1.70],0.8056393611020168
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23382,46,1.27 [0.50-3.19],0.6161945555889013
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23389,53,1.99 [0.87-4.57],0.1038529405182232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23773,210,0.92 [0.60-1.40],0.6919945163030601
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23862,54,1.15 [0.50-2.66],0.7426997735713442
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23742,179,0.97 [0.62-1.54],0.912824326189347
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22635,114,1.67 [0.94-2.99],0.0805652381643318
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19313,212,0.88 [0.58-1.36],0.5748327256107308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22704,59,0.62 [0.29-1.32],0.2117720947038186
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22701,56,1.33 [0.58-3.01],0.5011083352465102
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19145,44,0.84 [0.33-2.15],0.7234844939165821
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21969,53,1.17 [0.50-2.74],0.7145631362896596
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21676,208,0.91 [0.59-1.39],0.6613666213926394
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23578,417,0.87 [0.65-1.18],0.3865400008029241
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23419,258,0.86 [0.59-1.27],0.4569645341790305
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23220,59,1.03 [0.46-2.30],0.949808293243006
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23620,1704,0.84 [0.73-0.98],0.0235169118251212
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21237,1667,0.86 [0.74-1.00],0.044849347735633
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19147,46,0.76 [0.31-1.87],0.5545806047803234
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21309,101,1.53 [0.81-2.87],0.1864589918929992
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19351,250,0.79 [0.54-1.17],0.2466510186850135
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19143,42,0.38 [0.16-0.91],0.0290630977410427
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21827,2726,1.11 [0.98-1.25],0.0944213637244227
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19286,185,1.13 [0.71-1.81],0.6061078722400104
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19581,480,0.84 [0.63-1.11],0.2149806526178891
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23872,314,0.73 [0.52-1.02],0.0660768343451912
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23707,149,0.59 [0.36-0.97],0.0358218991202457
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19192,91,0.95 [0.49-1.83],0.8773723442081423
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19150,49,1.79 [0.71-4.50],0.2152496840449839
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23203,1995,0.95 [0.83-1.09],0.4833353114195304
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19275,174,0.80 [0.50-1.28],0.3448305107177893
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19274,173,0.73 [0.46-1.18],0.1998136063223994
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19563,462,1.23 [0.91-1.66],0.1696657863756428
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19173,72,0.77 [0.37-1.61],0.4869216375380054
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23701,143,0.56 [0.34-0.91],0.0201140540827125
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19639,538,0.74 [0.56-0.96],0.0233879196141792
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19587,486,1.03 [0.77-1.37],0.8563728912418069
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21532,64,1.59 [0.73-3.49],0.2466282548314416
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23188,4087,1.06 [0.96-1.17],0.2506296858557345
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21273,65,0.90 [0.42-1.92],0.7812922324386937
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21284,76,0.87 [0.44-1.75],0.7043850437865709
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23791,1790,1.02 [0.88-1.18],0.8033182939275532
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23795,1789,1.02 [0.88-1.18],0.8348362957659314
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21278,70,1.64 [0.77-3.50],0.1986713111120729
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23601,1385,0.96 [0.82-1.13],0.6453437045389425
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20406,1305,0.89 [0.75-1.05],0.1754184651359966
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23949,157,0.85 [0.52-1.39],0.5122912492336016
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23202,41,1.67 [0.63-4.46],0.3043518773143898
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22336,120,1.31 [0.74-2.33],0.3535995527833475
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22381,165,0.97 [0.60-1.57],0.8975940130011948
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19317,216,1.12 [0.73-1.73],0.5918405535019107
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22355,118,0.75 [0.43-1.31],0.3177430024805566
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1496,36,0.58 [0.21-1.57],0.281734993710666
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1592,150,1.47 [0.87-2.49],0.1542483576266174
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22261,24,1.91 [0.52-7.02],0.3300710032573808
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1483,24,0.87 [0.24-3.15],0.8376200362601233
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23548,1311,1.16 [0.97-1.37],0.0992567632623113
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23451,290,0.83 [0.58-1.19],0.2989355819860804
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21890,422,0.85 [0.63-1.14],0.2816740429055222
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19726,625,0.95 [0.74-1.23],0.7082483790786687
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23870,204,0.59 [0.39-0.89],0.0112941389506432
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23062,46,0.63 [0.26-1.50],0.2969149321378313
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Angina pectoris,22624,756,1.09 [0.87-1.37],0.4435683121266844
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23098,82,0.68 [0.35-1.31],0.2496351797214791
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23045,29,0.62 [0.21-1.85],0.3906093195191266
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23155,139,0.69 [0.42-1.15],0.1534848842593305
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15568,1277,0.88 [0.74-1.05],0.168310981314455
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,AV-block,21006,212,1.15 [0.75-1.78],0.5213208992025165
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23918,261,1.12 [0.76-1.64],0.5767734258088983
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cardiac arrest,14399,108,0.55 [0.31-0.97],0.0402634085741476
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20913,119,0.70 [0.40-1.21],0.2022461600518686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20866,72,0.99 [0.48-2.05],0.9786440463373836
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23956,28,0.79 [0.25-2.47],0.6858659172404583
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Conduction disorders,21428,634,0.94 [0.73-1.20],0.6216395426846193
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23154,1297,0.97 [0.82-1.15],0.7167768999740846
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21554,6358,0.94 [0.87-1.02],0.1516593631733779
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22655,217,0.55 [0.37-0.83],0.0039545588421312
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Endocarditis,20842,48,2.55 [1.03-6.30],0.0432214180910561
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23876,721,1.01 [0.80-1.27],0.9629019197124083
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertension,22102,5359,0.93 [0.85-1.01],0.0876273063720084
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22108,5365,0.93 [0.86-1.01],0.0980216288086824
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23855,37,1.01 [0.36-2.80],0.9875736533462852
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16896,153,0.61 [0.37-1.00],0.0491110252929079
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16810,67,0.54 [0.26-1.13],0.1007054036823998
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypotension,23842,923,0.90 [0.74-1.11],0.3309826413893876
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23301,86,1.10 [0.56-2.15],0.7836249585456718
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23333,1465,0.92 [0.78-1.08],0.2822401614997693
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23685,397,0.86 [0.63-1.17],0.3498472314997314
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21061,267,1.20 [0.81-1.76],0.3642002635482998
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23767,526,1.00 [0.76-1.31],0.988716424474568
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22288,420,0.95 [0.70-1.29],0.7489174318689934
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23935,76,0.73 [0.36-1.45],0.3667385044437005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23952,210,0.93 [0.61-1.42],0.7361641477542156
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Oesophageal varices,22473,35,1.02 [0.35-2.93],0.9748946386703816
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other aneurysm,23066,50,1.03 [0.44-2.44],0.9439772566996468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other arrhythmias,21110,316,0.78 [0.55-1.10],0.1547144566390496
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23076,60,1.07 [0.48-2.37],0.8768734899315294
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23189,173,1.08 [0.68-1.74],0.7401336643863794
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20943,149,1.21 [0.72-2.01],0.4729002056712472
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other disorders of veins,22513,75,0.49 [0.25-0.97],0.041816307561351
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22480,42,1.24 [0.48-3.22],0.6629076135873185
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22873,32,0.45 [0.16-1.25],0.1235938447341818
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22574,136,0.90 [0.53-1.54],0.7063482362979706
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21473,679,0.89 [0.70-1.13],0.3436771936371393
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22957,38,0.58 [0.22-1.52],0.2679222818934496
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23464,448,0.68 [0.51-0.91],0.0079733280759485
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23459,288,0.68 [0.47-0.97],0.0330597011775661
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23303,462,0.79 [0.59-1.05],0.1095963340808343
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14544,253,0.96 [0.65-1.42],0.8478294353465322
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23250,246,0.79 [0.54-1.17],0.2396974390033679
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22722,284,0.62 [0.43-0.88],0.0072609517844997
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23551,380,0.83 [0.61-1.14],0.244395036402585
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23888,499,0.78 [0.59-1.02],0.0678950599251758
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20980,186,0.53 [0.34-0.81],0.0038679169805875
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23452,281,0.68 [0.47-0.98],0.0368825414943932
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22975,134,0.80 [0.47-1.35],0.400889826190216
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23677,462,0.89 [0.67-1.18],0.4038229023743389
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23655,504,0.90 [0.68-1.18],0.4395741109839836
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23271,64,1.03 [0.48-2.21],0.9439925895499108
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23053,37,0.97 [0.35-2.67],0.9554355542652992
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23472,184,1.28 [0.81-2.04],0.2900226437219891
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23417,176,1.01 [0.63-1.61],0.9801701661006226
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Varicose veins,22822,384,0.82 [0.60-1.12],0.2165640677683401
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23026,83,0.40 [0.21-0.74],0.0035506894766541
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23774,602,0.77 [0.60-0.98],0.0358247592181107
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23923,197,1.53 [0.98-2.38],0.0613067890168932
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21291,1614,1.00 [0.86-1.17],0.9941221722743844
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Any mental disorder,23436,3759,0.97 [0.88-1.07],0.5414117960794631
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23898,234,1.41 [0.94-2.11],0.1004527851585364
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21399,1722,0.86 [0.75-1.00],0.0463354745398134
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19754,77,0.66 [0.34-1.31],0.2357689647540983
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Smoking dependency,23606,1050,1.10 [0.91-1.33],0.3100565596952878
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20895,1218,1.16 [0.97-1.39],0.1012613451410531
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Vascular dementia,23537,92,0.63 [0.34-1.18],0.1494231798046085
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Alzheimer disease,23958,322,0.88 [0.63-1.24],0.4744092901217487
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16399,51,0.62 [0.27-1.46],0.2751586231810308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Bell's palsy,22086,72,0.76 [0.37-1.56],0.4605200674207825
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22569,555,0.69 [0.54-0.90],0.0049298394247404
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Cerebral cysts,23607,188,0.85 [0.54-1.32],0.4635725098035034
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23894,237,0.82 [0.55-1.22],0.3348919756916535
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23536,38,1.29 [0.46-3.55],0.6287903178189105
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23947,43,1.06 [0.41-2.71],0.9066741925237836
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23464,45,0.60 [0.25-1.47],0.2654068034619762
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Epilepsy,22687,243,0.71 [0.48-1.04],0.0745535149395776
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23590,1146,0.85 [0.71-1.02],0.0768136775389997
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23917,308,0.77 [0.55-1.09],0.1462386344282725
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23415,2524,0.96 [0.85-1.09],0.5640366718324545
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Generalized epilepsy,23642,40,0.71 [0.28-1.81],0.4715441578413013
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Hemiplegia,23847,190,0.89 [0.57-1.39],0.6091947384003542
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Hydrocephalus,23475,56,1.04 [0.46-2.37],0.929352114241741
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23940,65,0.75 [0.36-1.58],0.4531538753470325
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22123,109,0.53 [0.30-0.92],0.0253668633860036
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22069,55,1.11 [0.48-2.55],0.8115817109425328
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Memory loss,23423,92,0.63 [0.34-1.18],0.1486210579015009
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Migraine,22879,435,1.17 [0.87-1.57],0.2925206951774214
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23856,393,1.14 [0.83-1.55],0.4158546644079232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Motor neuron disease,16488,115,0.70 [0.39-1.23],0.2100296639086383
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23759,126,0.54 [0.32-0.89],0.01529747935483
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23230,1216,0.75 [0.63-0.89],0.0012174351696174
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Neurological diseases,22548,3230,0.83 [0.74-0.92],0.0004749656117299
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23623,125,0.61 [0.36-1.04],0.0717967728092386
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22387,373,0.82 [0.60-1.12],0.2177402301006665
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23908,195,1.02 [0.65-1.58],0.9456905982497208
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19379,579,0.72 [0.56-0.92],0.0101787583315722
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23478,59,0.95 [0.43-2.12],0.9089586352435548
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23530,111,0.75 [0.42-1.33],0.3286090946687567
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23752,143,0.71 [0.43-1.17],0.1773533932811068
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22093,79,0.60 [0.31-1.17],0.1313270917265854
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other headache syndromes,22513,69,0.64 [0.31-1.32],0.2265344033536666
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other neurological diseases,23855,436,0.79 [0.59-1.05],0.1002247729606272
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other sleep disorders,22791,347,0.61 [0.44-0.84],0.0021686260561284
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Parkinson's disease,23936,144,0.91 [0.54-1.52],0.7151610238271995
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23491,72,0.85 [0.42-1.73],0.6548879237286465
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Restless leg syndrome,23958,77,0.45 [0.23-0.87],0.0170679758711307
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Sleep apnoea,23801,276,0.70 [0.49-1.01],0.053730517890028
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23747,34,0.63 [0.23-1.74],0.3705074692856579
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23949,140,0.78 [0.47-1.31],0.3526683603233047
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22076,62,0.73 [0.34-1.57],0.420203182615569
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23958,325,0.89 [0.63-1.26],0.5098251477589195
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23496,89,0.63 [0.33-1.19],0.1553148002981114
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23441,93,1.26 [0.66-2.41],0.4849799569663537
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23556,428,0.91 [0.67-1.22],0.514043329984618
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23834,143,1.40 [0.82-2.38],0.2148138755632015
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22991,53,0.32 [0.15-0.68],0.0030058647560178
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22987,49,0.99 [0.42-2.33],0.9766067664385204
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23851,57,0.55 [0.25-1.19],0.1273194602044715
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23705,149,0.65 [0.40-1.07],0.0904909376646581
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1490,30,0.67 [0.22-2.00],0.4698627741991991
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1779,55,0.64 [0.29-1.43],0.2772391948804964
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23432,84,0.89 [0.45-1.73],0.7236040870808005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23807,920,1.27 [1.03-1.56],0.0243122245218732
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23594,656,0.81 [0.64-1.03],0.086340614162271
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23204,266,0.86 [0.59-1.25],0.4383444724122124
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23885,757,0.86 [0.69-1.08],0.1943909995971203
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23946,65,0.65 [0.31-1.37],0.2611934218974102
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23818,690,0.82 [0.65-1.03],0.0868386161695697
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23919,363,0.75 [0.54-1.03],0.0749893245617153
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23874,187,0.90 [0.57-1.41],0.6450302551786157
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22976,38,0.64 [0.24-1.70],0.3665600252420556
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22979,41,1.10 [0.41-2.93],0.8494887149593756
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22999,61,1.17 [0.53-2.58],0.704776911036768
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23878,624,0.99 [0.78-1.27],0.9624246513345324
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23409,155,0.97 [0.59-1.59],0.9071109800592216
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23186,58,0.61 [0.28-1.34],0.2218401060392285
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23647,91,0.75 [0.40-1.41],0.3667564200547739
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23837,281,0.77 [0.54-1.11],0.1595627143248834
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23314,186,0.72 [0.46-1.11],0.1368381084429351
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23808,121,0.72 [0.41-1.24],0.2306682169865747
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23658,404,1.07 [0.79-1.46],0.652895332468844
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23488,140,1.15 [0.68-1.95],0.5952733223100376
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22383,2223,0.96 [0.84-1.10],0.5815617256497624
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23802,246,0.73 [0.50-1.08],0.1110770322454734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23937,141,0.88 [0.53-1.47],0.6332244439538086
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23275,337,0.71 [0.51-0.99],0.0438850545726018
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23615,59,0.68 [0.31-1.49],0.3344901517939176
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23932,51,0.62 [0.27-1.44],0.2683889770735964
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23020,82,0.54 [0.28-1.03],0.0595351850995381
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23064,126,1.16 [0.67-2.02],0.594924805510788
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22980,93,1.54 [0.80-2.96],0.1982349926314084
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23185,57,1.98 [0.89-4.40],0.0934888595051228
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22945,58,1.09 [0.49-2.46],0.8280092816131326
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23360,106,1.40 [0.76-2.56],0.2800568254185203
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23412,158,0.58 [0.36-0.94],0.0252905476769323
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23050,112,0.56 [0.32-0.98],0.0440952807155917
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22969,82,1.33 [0.67-2.63],0.4178068841362569
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22947,60,1.34 [0.59-3.04],0.4798992023485074
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21995,1835,0.85 [0.73-0.98],0.0260232231723471
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23016,78,1.32 [0.65-2.67],0.4360733754240827
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23730,382,0.98 [0.72-1.34],0.9086601977767768
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23388,40,0.70 [0.27-1.82],0.4631959304788253
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23493,145,0.59 [0.36-0.98],0.0395689516804643
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23733,100,0.91 [0.49-1.68],0.7592836134259369
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23919,91,1.03 [0.54-1.97],0.920231758479868
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23851,125,0.61 [0.36-1.03],0.0619064253544686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23698,65,1.28 [0.59-2.77],0.5320656124874417
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23699,66,1.19 [0.56-2.57],0.6488558215088411
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23864,707,0.85 [0.68-1.07],0.1717234141918595
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23641,484,0.86 [0.65-1.14],0.2906918767492598
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23260,103,0.63 [0.35-1.13],0.1201170895330119
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23233,76,1.00 [0.49-2.03],0.9993493347837832
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute pharyngitis,23713,76,0.56 [0.29-1.10],0.0947542886204719
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23847,210,0.77 [0.51-1.16],0.2132436177876195
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23692,55,1.04 [0.46-2.34],0.9336347549989656
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,All influenza,22471,114,0.77 [0.43-1.36],0.3695615564381491
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22470,113,0.79 [0.45-1.41],0.4334156235628796
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17032,114,1.08 [0.61-1.93],0.7925661391393355
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Allergic rhinitis,23838,249,1.01 [0.68-1.48],0.9792123439620328
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18592,1827,0.87 [0.75-1.00],0.056666890909886
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18721,1803,0.87 [0.75-1.00],0.0581862088631022
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23595,117,0.84 [0.48-1.48],0.5505734844577244
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22420,63,0.77 [0.36-1.64],0.4940822661996956
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Bronchiectasis,20686,346,0.84 [0.61-1.17],0.3155240746994476
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20400,60,0.87 [0.39-1.93],0.7291568553529463
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22942,2602,0.86 [0.76-0.97],0.0114068218680871
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22842,59,0.58 [0.27-1.25],0.16546663494402
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic sinusitis,22910,127,0.57 [0.34-0.97],0.0367551145410873
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23805,906,0.86 [0.70-1.05],0.1361813441641034
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Deviated nasal septum,22848,65,0.46 [0.23-0.93],0.0313159877092838
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22118,4480,0.88 [0.80-0.96],0.0045306999076283
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23077,294,0.71 [0.50-1.01],0.0577918686910734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Early onset COPD,23183,284,1.04 [0.72-1.50],0.8360219519246801
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Emphysema,20572,232,0.75 [0.50-1.12],0.1559076456653154
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22481,206,0.75 [0.49-1.14],0.1819093050836566
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23779,1422,0.96 [0.82-1.14],0.6651983175245391
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Interstitial lung disease,22516,241,0.89 [0.60-1.32],0.5588889836479916
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Later onset COPD,23144,622,0.80 [0.62-1.02],0.0690547943905631
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23952,191,0.97 [0.62-1.52],0.9008737204862134
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Nasal polyp,22842,59,0.55 [0.26-1.18],0.1245575974458435
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23757,816,0.93 [0.75-1.16],0.535136886260418
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of pleura,23789,1517,0.82 [0.71-0.96],0.0159337738201778
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23472,689,0.84 [0.67-1.05],0.130085917059521
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other pleural conditions,22307,35,0.62 [0.23-1.69],0.3553559425936773
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23882,305,0.96 [0.68-1.37],0.8251951691443273
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23877,1033,0.80 [0.67-0.97],0.0244919134228702
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pleural effusion,22995,723,0.91 [0.72-1.14],0.4010458874556915
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pleural plaque,22312,40,0.89 [0.33-2.37],0.8146012487579807
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23562,1205,0.95 [0.80-1.14],0.580839121011415
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23924,163,0.94 [0.58-1.52],0.8003831767112632
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pneumothorax,22360,88,0.55 [0.30-1.03],0.0635148589998448
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pollen allergy,23936,210,1.09 [0.71-1.66],0.692145082495729
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pulmonary oedema,23631,54,0.75 [0.33-1.71],0.4923854192613959
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16962,44,0.65 [0.26-1.65],0.3651654570227344
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23738,797,0.95 [0.76-1.18],0.6142551817610223
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23032,249,0.99 [0.68-1.46],0.9733782779975356
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Viral pneumonia,22542,185,0.64 [0.41-1.00],0.0490210416652218
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23602,145,0.69 [0.42-1.15],0.1572760194914973
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11510,91,1.11 [0.57-2.17],0.7559648965338224
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17132,36,1.72 [0.60-4.98],0.3139206302557458
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute appendicitis,23786,122,0.89 [0.52-1.54],0.6898061698011269
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute gastritis,17967,70,1.04 [0.50-2.18],0.9127135103553196
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute pancreatitis,21952,142,1.09 [0.65-1.84],0.7370376730565211
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute peritonitis,23450,73,1.10 [0.54-2.28],0.7877418920566941
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23200,33,1.70 [0.56-5.12],0.3489135511977752
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Barrett oesophagus,18205,308,1.28 [0.90-1.83],0.1748297884784895
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21883,73,1.19 [0.57-2.47],0.6497316786204221
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23590,73,1.19 [0.57-2.48],0.645827376340576
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholecystitis,21967,157,0.80 [0.50-1.31],0.3805747790731187
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholelithiasis,22854,1044,1.16 [0.95-1.40],0.1364304218002418
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Chronic gastritis,18192,295,0.87 [0.61-1.24],0.4277919331720342
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21846,36,1.13 [0.40-3.15],0.8217396532440682
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23886,68,1.29 [0.60-2.77],0.5119852978303636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Coeliac disease,22614,127,0.87 [0.51-1.48],0.5981130451920147
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Collagenous colitis,22296,97,0.89 [0.48-1.66],0.7162590774307447
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23833,139,1.17 [0.70-1.98],0.5480406972636114
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Constipation,23665,1473,0.91 [0.78-1.07],0.2716780930542365
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn disease,22274,75,1.10 [0.54-2.23],0.7946186772282302
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23644,53,1.08 [0.46-2.51],0.8651813799918316
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22276,77,1.10 [0.54-2.21],0.7976901542095299
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Dental caries,23232,203,0.84 [0.55-1.27],0.4054135851567544
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22518,2136,0.89 [0.78-1.01],0.0734633892437933
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of appendix,23825,161,1.10 [0.68-1.78],0.702419525387087
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of liver,23869,702,1.12 [0.89-1.42],0.3357324104178317
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21943,4046,0.95 [0.86-1.05],0.2897707187198423
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23546,517,0.81 [0.62-1.05],0.1141958405012414
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23849,472,1.01 [0.76-1.34],0.9456915254332604
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23131,102,0.89 [0.49-1.62],0.7070645627520712
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23002,56,1.52 [0.66-3.52],0.3247290053082607
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23699,1212,1.00 [0.84-1.20],0.971614293518808
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of tongue,23006,92,0.55 [0.30-1.01],0.0556329062038781
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23204,1394,1.08 [0.92-1.28],0.3549441971655666
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19889,2793,1.04 [0.93-1.17],0.4731613735451468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Duodenal ulcer,18015,118,0.77 [0.44-1.34],0.3533797311872322
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23909,98,0.81 [0.44-1.51],0.5121423050188945
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23872,57,1.24 [0.56-2.75],0.6034703817532945
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23253,86,1.44 [0.73-2.84],0.2968938893293814
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17198,102,1.16 [0.63-2.15],0.6258272379358072
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Functional dyspepsia,18482,585,1.07 [0.83-1.38],0.5905908381033314
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastric ulcer,18201,304,0.75 [0.53-1.06],0.1064904140432998
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20344,2447,0.96 [0.85-1.09],0.5135743427402342
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18315,418,0.76 [0.57-1.03],0.07613085567495
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18725,7344,0.98 [0.91-1.05],0.5470885229558562
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,GI-bleeding,23455,968,1.05 [0.86-1.28],0.6279584407504264
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23091,62,0.46 [0.22-0.96],0.039629690803409
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17942,1103,1.04 [0.87-1.26],0.6523582513283643
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23201,34,0.63 [0.23-1.75],0.3770611028443205
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Hernia,22908,2526,0.90 [0.80-1.02],0.1026445548869131
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Impacted teeth,23880,52,1.28 [0.55-2.95],0.5669439103304486
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Impaction of intestines,17155,59,1.36 [0.60-3.06],0.4595006846095442
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Inguinal hernia,20536,154,0.89 [0.54-1.46],0.6441717062000762
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17178,82,0.63 [0.33-1.22],0.1700879481413768
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22641,154,0.75 [0.46-1.22],0.2450848413887097
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17804,708,1.06 [0.84-1.33],0.6328368299797664
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23946,303,1.23 [0.86-1.76],0.2608098860232474
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22919,720,1.08 [0.86-1.36],0.527820108623582
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23163,964,1.09 [0.89-1.33],0.40567601749377
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18031,134,0.56 [0.33-0.93],0.02540840400277
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophagitis,18402,505,1.01 [0.77-1.34],0.9214018931783884
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23917,141,1.27 [0.76-2.15],0.3624058765586968
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20435,53,0.65 [0.28-1.48],0.3011688173639631
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18195,1099,1.05 [0.87-1.27],0.5865683714019646
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22071,261,0.81 [0.55-1.18],0.2628122137486164
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21973,163,1.62 [0.99-2.64],0.0536847706672511
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestine,18472,1376,1.20 [1.02-1.42],0.0323017864616899
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestines,22056,4960,1.02 [0.93-1.11],0.6945228594701975
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23005,204,0.95 [0.62-1.46],0.8309075336665207
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of liver,23748,581,1.13 [0.88-1.47],0.342465617992667
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18424,527,1.16 [0.88-1.52],0.2899189292363671
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21945,135,0.97 [0.57-1.66],0.9165644490903788
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23793,416,1.00 [0.74-1.36],0.9778542374233286
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18843,946,0.92 [0.76-1.13],0.4407367977077205
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23471,984,1.06 [0.87-1.29],0.5680960139696762
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23182,153,0.76 [0.47-1.23],0.2572447474069617
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18621,1525,0.93 [0.80-1.09],0.379132431145272
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19726,1829,0.97 [0.84-1.12],0.7170777280072265
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23260,93,1.13 [0.59-2.15],0.7108939560592997
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23051,852,1.13 [0.92-1.40],0.2503402263532963
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17387,291,1.19 [0.82-1.71],0.359675043936083
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23862,66,1.06 [0.51-2.22],0.872525891436342
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17526,430,0.97 [0.72-1.31],0.8473449999606188
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22608,121,0.96 [0.55-1.68],0.8852128014183468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23950,65,1.18 [0.55-2.53],0.6794854657237424
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23030,116,0.99 [0.56-1.74],0.9602691416786412
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Toxic colitis,22254,55,1.98 [0.83-4.69],0.122779279015137
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18107,210,1.16 [0.75-1.79],0.4942730540722897
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcerative colitis,22346,147,1.30 [0.78-2.17],0.3075391764762218
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22323,124,1.49 [0.85-2.59],0.1634024767443745
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Umbilical hernia,20536,154,1.11 [0.67-1.84],0.6731422647918677
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17265,169,0.47 [0.30-0.74],0.00094602536229
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ventral hernia,20605,223,1.01 [0.67-1.52],0.9714140436727304
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Volvulus,17169,73,0.65 [0.32-1.30],0.2262971698338554
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23884,223,1.09 [0.72-1.65],0.6960083046792256
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23680,74,0.72 [0.36-1.44],0.3522423908788853
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22155,198,1.22 [0.78-1.89],0.3856720330420984
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23480,552,0.80 [0.62-1.04],0.0965846640083122
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23060,132,0.71 [0.42-1.20],0.2050693006799846
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22237,280,0.88 [0.61-1.28],0.516248506041567
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23677,247,0.84 [0.57-1.23],0.3715721224603781
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23856,426,0.83 [0.62-1.12],0.2226039041647697
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23476,46,0.77 [0.32-1.86],0.5549923013519231
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22553,2772,0.93 [0.83-1.05],0.2308487397582855
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23560,408,0.84 [0.63-1.14],0.2647446960701808
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23432,280,0.89 [0.62-1.28],0.5388250343728249
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23670,742,0.79 [0.63-0.99],0.0364150596652492
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23941,65,0.96 [0.45-2.05],0.916898452261663
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22045,88,0.64 [0.34-1.20],0.1639304481908003
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23192,40,0.65 [0.26-1.66],0.3716143482065235
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23663,233,0.83 [0.56-1.23],0.345940937047674
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22332,375,1.04 [0.76-1.43],0.8056459017040409
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22003,46,0.65 [0.27-1.57],0.3375811414364185
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23868,70,0.56 [0.28-1.13],0.1075280804736129
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23060,132,0.73 [0.43-1.23],0.2369712117378871
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23755,149,0.92 [0.56-1.51],0.7342783317058134
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23472,42,1.86 [0.68-5.04],0.2252511305031898
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22013,56,0.98 [0.43-2.23],0.9650340008644308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23366,1409,0.99 [0.84-1.17],0.9121503520572996
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22362,405,1.01 [0.74-1.37],0.965020284439074
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22007,50,0.58 [0.25-1.35],0.2079844329054939
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23883,277,1.02 [0.70-1.47],0.9338866274380244
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23504,74,0.71 [0.35-1.41],0.3234342563683209
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23821,215,1.00 [0.66-1.53],0.9824695390548308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23910,249,1.07 [0.72-1.58],0.7478878308277576
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22101,144,1.16 [0.69-1.94],0.5714296260346108
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22187,230,1.27 [0.84-1.92],0.2525526023908556
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23899,238,1.05 [0.70-1.57],0.8042931897140636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22132,175,0.75 [0.47-1.18],0.2142829862395871
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23926,128,0.76 [0.45-1.30],0.3242392612373521
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20433,118,0.61 [0.36-1.05],0.0720752660109117
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21746,5587,0.78 [0.72-0.84],1.3068468809081536e-09
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20529,4370,0.75 [0.68-0.82],8.03604962049993e-10
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20382,67,0.83 [0.40-1.74],0.6285552486919288
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20537,137,0.61 [0.37-1.02],0.0576557069699363
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20583,183,0.80 [0.51-1.25],0.3271451964983901
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23708,102,0.73 [0.40-1.32],0.302124059935454
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20502,102,0.75 [0.41-1.38],0.3556804072431206
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17366,1207,0.76 [0.64-0.91],0.002148278547787
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23818,200,0.61 [0.40-0.92],0.0195415019593208
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20915,515,0.57 [0.43-0.73],1.9329831434770025e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20112,7118,0.82 [0.76-0.88],1.1185995303364321e-07
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21457,121,1.16 [0.66-2.04],0.6115948339887427
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20434,119,0.68 [0.39-1.18],0.1679959845156964
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20922,607,0.83 [0.65-1.06],0.1286263210301957
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23054,2654,0.76 [0.68-0.85],4.954290751933133e-06
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20473,158,1.60 [0.98-2.62],0.058324350819518
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20658,343,0.79 [0.57-1.09],0.1437115841292529
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20471,156,1.28 [0.78-2.11],0.3217049845648196
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23085,96,0.79 [0.42-1.47],0.4569687050780647
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17809,1650,0.82 [0.70-0.96],0.0114109563282089
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16338,179,0.50 [0.32-0.80],0.0034368035121231
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23945,176,0.58 [0.37-0.92],0.019629627946556
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16252,93,0.54 [0.29-1.00],0.0483609230827228
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16660,501,0.59 [0.45-0.76],7.848629372660462e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20609,294,0.64 [0.45-0.90],0.0106665579244331
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16714,555,0.77 [0.60-1.00],0.0516769089333683
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20459,59,0.78 [0.35-1.74],0.5407765692984525
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21028,628,0.70 [0.55-0.89],0.0039530133447898
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20693,293,0.80 [0.56-1.14],0.2228405015220209
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16675,516,0.80 [0.61-1.05],0.1147296144990756
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20389,74,0.93 [0.46-1.89],0.8442336808704723
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20376,61,0.48 [0.23-1.01],0.0529253795012731
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21381,45,0.47 [0.20-1.13],0.0934155421252261
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23543,2207,0.85 [0.74-0.96],0.012364039686717
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22924,1588,0.84 [0.72-0.98],0.0258919373903223
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23774,521,0.83 [0.64-1.09],0.1829994475797589
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18830,2671,0.67 [0.59-0.75],1.1721866394630115e-11
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16220,61,0.42 [0.20-0.88],0.0211875116015568
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20404,89,0.69 [0.36-1.31],0.2558812768442469
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16201,42,1.26 [0.47-3.41],0.6468124827388172
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16340,181,0.80 [0.51-1.26],0.3393798489604585
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21596,260,0.79 [0.55-1.16],0.2314735785560123
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21835,499,0.84 [0.64-1.11],0.2142844671786267
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23934,96,0.57 [0.31-1.04],0.064893810219753
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22187,1787,0.76 [0.66-0.87],0.0001337790257995
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20428,113,0.57 [0.33-0.99],0.0470292409225486
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16361,202,0.64 [0.42-0.98],0.0407229762469363
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21111,711,0.73 [0.58-0.91],0.0058769767374453
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18390,2231,0.70 [0.61-0.79],3.0657548349103654e-08
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23108,119,0.70 [0.40-1.22],0.2048861499350538
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23940,73,0.63 [0.32-1.26],0.1900370658702989
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20382,67,0.84 [0.40-1.77],0.6390642097973167
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21617,1302,0.82 [0.69-0.97],0.0202656453334152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20386,71,0.55 [0.27-1.10],0.0894636050396733
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17920,1761,0.78 [0.67-0.90],0.0007651810462132
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21462,126,0.99 [0.57-1.72],0.9753884755090538
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20365,50,0.46 [0.20-1.03],0.0590773598042767
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20576,176,0.83 [0.52-1.31],0.4214653576015046
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20822,507,0.85 [0.65-1.12],0.2589071994230522
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23440,451,1.02 [0.76-1.36],0.896687641889527
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20966,566,0.80 [0.62-1.03],0.0854169915364919
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23786,508,0.90 [0.68-1.18],0.4273154624164484
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23932,58,0.65 [0.30-1.42],0.2806703782841485
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20511,196,0.75 [0.49-1.16],0.1930790853193182
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18343,800,0.69 [0.56-0.86],0.0008320618592704
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20905,590,0.77 [0.60-0.99],0.0420704465260353
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20424,109,2.10 [1.18-3.73],0.0116792986322081
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16233,74,1.07 [0.51-2.23],0.8617477302113852
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18490,2331,0.75 [0.66-0.85],8.723341050426094e-06
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16900,741,0.61 [0.48-0.76],1.0594464205415408e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23244,255,1.08 [0.73-1.60],0.6867071630768358
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23908,70,0.48 [0.24-0.96],0.0380844001165307
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21947,49,0.64 [0.27-1.52],0.3087022219445587
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16233,74,0.56 [0.28-1.12],0.1025607563528497
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20500,100,0.65 [0.36-1.19],0.1627307648753722
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16684,525,0.74 [0.57-0.97],0.0270114134523956
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20594,279,0.54 [0.38-0.78],0.0008110998965219
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20650,250,0.75 [0.51-1.10],0.14536087025544
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20641,241,0.49 [0.33-0.71],0.0002135183874641
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18455,74,0.59 [0.30-1.19],0.1425406052853594
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23938,64,0.71 [0.34-1.49],0.3619466086125236
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20870,555,0.67 [0.52-0.86],0.0016401846026516
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23139,150,0.71 [0.44-1.16],0.1748361159521365
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22788,2473,0.82 [0.72-0.92],0.0010998955597651
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20450,135,0.64 [0.38-1.07],0.0895994927976031
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20893,493,0.76 [0.58-1.01],0.0545517528844526
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22411,229,0.81 [0.54-1.21],0.2935005616347
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20621,221,0.59 [0.40-0.88],0.0104794213864469
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21929,1529,0.73 [0.63-0.86],9.182265146661662e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21438,1038,0.74 [0.61-0.89],0.0018671462104628
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20370,55,0.71 [0.31-1.60],0.4044275877386997
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23205,216,1.06 [0.70-1.61],0.7725861473798958
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20491,176,0.92 [0.58-1.47],0.7376984308022536
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20429,114,0.63 [0.36-1.10],0.1048829719542512
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16204,45,0.57 [0.23-1.40],0.2178103613668129
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23117,1045,1.01 [0.83-1.23],0.907987963759752
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17912,87,1.27 [0.66-2.44],0.4752630344004745
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23347,100,1.30 [0.70-2.41],0.4005917170516244
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23819,201,0.91 [0.59-1.39],0.6540544078826183
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23639,21,0.52 [0.14-1.89],0.3202787340035659
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23232,1160,0.96 [0.80-1.15],0.6401007154487186
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23812,59,0.77 [0.35-1.72],0.5276054369822779
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23784,205,0.73 [0.48-1.11],0.1391338848223776
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Cystitis,21155,220,0.77 [0.51-1.17],0.2215434586368583
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Dialysis,22118,46,0.67 [0.28-1.62],0.3727828344890393
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23535,288,1.03 [0.72-1.47],0.8748991860881886
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Endometriosis,17975,150,1.41 [0.86-2.33],0.1741697401368743
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18163,338,1.09 [0.79-1.51],0.5925703294428566
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18696,871,0.89 [0.72-1.10],0.270732801315482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18594,4310,0.92 [0.84-1.01],0.0889725664930954
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23808,55,0.84 [0.37-1.92],0.6851074529018379
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21950,179,0.78 [0.50-1.23],0.2823077668554195
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23473,347,0.98 [0.71-1.37],0.9239284656918152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Irregular menses,23552,106,1.47 [0.82-2.65],0.1970920429253954
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18091,266,0.99 [0.69-1.42],0.9522431678363472
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21000,65,0.92 [0.43-1.96],0.8217819564846685
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19945,2120,0.94 [0.83-1.08],0.3830733538974576
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17944,119,0.70 [0.41-1.20],0.1913689591421202
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23950,57,1.19 [0.52-2.73],0.6721484195269264
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23949,71,0.82 [0.40-1.70],0.5994095435403998
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22863,1928,0.89 [0.77-1.02],0.0869578577839598
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21349,414,0.63 [0.47-0.84],0.0017334079642609
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23348,101,0.82 [0.45-1.49],0.5169202191368787
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23906,327,0.74 [0.53-1.03],0.0770613623124586
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23905,78,0.53 [0.27-1.03],0.0629652429407559
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22588,1653,0.92 [0.79-1.07],0.2707257617882451
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23307,181,1.14 [0.72-1.80],0.5737150097070854
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17960,135,1.04 [0.61-1.76],0.8917090739038469
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18166,341,1.20 [0.86-1.68],0.2866070157901246
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17925,100,0.67 [0.37-1.21],0.1804692832792725
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18004,179,1.48 [0.93-2.35],0.101542678007611
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21997,226,0.73 [0.49-1.08],0.1188417179257267
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23687,108,0.74 [0.41-1.32],0.3055862869961505
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18082,257,0.84 [0.58-1.22],0.3636883022492937
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17917,92,1.05 [0.56-1.98],0.872619921601004
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18382,557,1.01 [0.78-1.30],0.9697855416300312
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17965,140,0.82 [0.49-1.38],0.4620292685082188
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18342,517,0.86 [0.66-1.13],0.2782141891086155
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23787,34,1.00 [0.35-2.83],0.9946207237597452
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23804,2033,0.99 [0.86-1.14],0.9060428036100412
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21917,146,1.09 [0.66-1.81],0.736095369209721
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22155,83,0.52 [0.27-0.99],0.0450197599546242
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23650,32,0.61 [0.22-1.72],0.3517554844327325
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21061,126,1.01 [0.58-1.74],0.9750552503095123
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23849,231,0.79 [0.53-1.18],0.2503036525451513
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17944,119,1.02 [0.58-1.79],0.9417460875020334
